Antibody Discovery Market is segmented By Type of Service Offered (Antigen Designing, Hit Generation...
Market Size in USD Bn
CAGR12.5%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 12.5% |
Market Concentration | High |
Major Players | WuXi Biologics, GenScript, Genmab, Harbour BioMed, ImmunoPrecise and Among Others |
The antibody discovery market is estimated to be valued at USD 3.15 Bn in 2025 and is expected to reach USD 7.18 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.5% from 2025 to 2032. Advances in antibody engineering technologies like phage display have increased the demand for antibody discovery services. The market is driven by the rising prevalence of chronic and infectious diseases and the growth of therapeutic antibodies to treat such disorders.
The antibody discovery market is expected to witness significant growth due to increasing R&D spending by pharmaceutical and biotechnology companies. Further, the rise in research activities pertaining to antibody-based therapeutics and diagnostics will support the growth of this market. Additionally, the growing focus on development of next-generation antibody therapeutics is anticipated to provide lucrative opportunities for vendors in the coming years.